Christine Walsh
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, BRCA gene mutations in cancer, Endometrial and Cervical Cancer Treatments, Cancer-related molecular mechanisms research, PARP inhibition in cancer therapy
Most-Cited Works
- → Association of Type and Location ofBRCA1andBRCA2Mutations With Risk of Breast and Ovarian Cancer(2015)494 cited
- → PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline(2020)304 cited
- → Two decades beyond BRCA1/2: Homologous recombination, hereditary cancer risk and a target for ovarian cancer therapy(2015)246 cited
- → Coexisting Ovarian Malignancy in Young Women With Endometrial Cancer(2005)229 cited
- → ABCA Transporter Gene Expression and Poor Outcome in Epithelial Ovarian Cancer(2014)227 cited
- → p53 regulates cell survival by inhibiting PIK3CA in squamous cell carcinomas(2002)214 cited
- → Germline Mutation in BRCA1 or BRCA2 and Ten-Year Survival for Women Diagnosed with Epithelial Ovarian Cancer(2014)158 cited
- → Association of Wearable Activity Monitors With Assessment of Daily Ambulation and Length of Stay Among Patients Undergoing Major Surgery(2019)149 cited
- → DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers(2014)130 cited
- → Cyclin E1 and RTK/RAS signaling drive CDK inhibitor resistance via activation of E2F and ETS(2014)119 cited